首页 > 用药指导 > 文章详情

Sotorasib (AMG510) English Patient Information Leaflet

发布时间:2023-06-15 17:48:08 阅读:105 来源:问药网
分享至

分享到微信朋友圈

×

打开微信,点击底部的“发现”,

使用“扫一扫”即可将网页分享至朋友圈。

索托拉西布AMG510

索托拉西布AMG510 生产厂家:老挝国立第二制药厂 功能主治:KRAS抑制剂,肺癌新特药 用法用量:用法用量  1.推荐剂量为960mg(8片),每天一次,直至疾病进展或出现不可接受的毒性。  如果漏服超过当日服药时间6小时以上,请跳过该剂量。  第二天服药仍按照原剂量服用,不要同时服用2剂来弥补错过的剂量。  吞下整粒药片,不要咀嚼、压碎或分裂药片。  2.建议的剂量减少  剂量降低剂量  首次剂量降低480mg(4片),每日一次  第二次剂量降低240mg(2片),每日一次  3.不良反应的推荐剂量调整  不良反应严重程度*本品剂量调整  肝毒性2级(谷丙转氨酶或者谷草转氨酶升高伴有症状)  暂停使用本品直至≤1级或基线水平;  恢复后,以下一个较低剂量水平恢复使用本品  3级(谷丙转氨酶或者谷草转氨酶升高)  谷丙转氨酶或者谷草转氨酶 > 3×ULN与总胆红素> 2 × ULN永久停用本品  间质性肺病(ILD)/肺炎任何级别  如果怀疑ILD/肺炎,暂停使用本品;  如果确诊ILD/肺炎,永久停用本品  恶心或呕吐3~4级  暂停使用本品直至≤1级或基线水平;  恢复后,以下一个较低剂量水平恢复使用本品  腹泻3~4级  暂停使用本品直至≤1级或基线水平;  恢复后,以下一个较低剂量水平恢复使用本品  其他不良反应3~4级  暂停使用本品直至≤1级或基线水平;  恢复后,以下一个较低剂量水平恢复使用本品
查看详情
  Sotorasib (AMG510) is a medication used to treat a certain type of lung cancer called non-small cell lung cancer (NSCLC). This medication works by blocking the activity of a protein called KRAS G12C, which is often present in NSCLC tumors.
  How to take Sotorasib (AMG510)?
索托拉西布AMG510  Sotorasib (AMG510) is taken orally, in the form of a tablet. It is usually taken once a day, with or without food, as directed by your healthcare provider. Do not crush, chew, or break the tablet. Swallow it whole with a glass of water.
  Side effects of Sotorasib (AMG510)
  Sotorasib (AMG510) may cause side effects in some patients. The most common side effects include diarrhea, nausea, fatigue, decreased appetite, and cough. However, these side effects usually improve within a few days or weeks of starting treatment.
  Some patients may experience more serious side effects such as lung inflammation, liver damage, or blood clotting disorders. If you experience any of these symptoms or any other side effects that are concerning to you, contact your healthcare provider right away.
  Precautions when taking Sotorasib (AMG510)
  Before taking Sotorasib (AMG510), tell your healthcare provider about any allergies you may have to medications, especially any allergies to other cancer medications. It is also important to inform your healthcare provider if you have any other medical conditions, such as liver or kidney disease, blood clotting disorders, or lung problems.
  Sotorasib (AMG510) may interact with other medications you are taking, so it is important to tell your healthcare provider about any other medications you are taking, including prescription medications, over-the-counter medications, herbal remedies, or dietary supplements.
  It is also important to avoid using Sotorasib (AMG510) during pregnancy or breastfeeding. If you are pregnant or breastfeeding, talk to your healthcare provider about the risks and benefits of using this medication.
  Conclusion
  Sotorasib (AMG510) is a medication used to treat NSCLC by blocking the activity of a protein called KRAS G12C. While it may cause side effects, most of these are mild and go away on their own. However, if you experience any concerning symptoms, be sure to contact your healthcare provider right away. Make sure to inform your healthcare provider about any allergies or medical conditions you have, as well as any other medications you are taking.